Publications by authors named "Gary Fanger"

Claim this Profile
T
Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren's syndrome-like disease.
Ali Akgul, Christian Furlan Freguia, Massimo Maddaloni, Carol Hoffman, Alexandria Voigt, Neil A Fanger, Gary R Fanger

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sjögren's Syndrome Treatments in the Microbiome Era.
Christian Furlan Freguia, David W Pascual, Gary R Fanger

Adv Geriatr Med Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy.
Matthew E Griffin, Juliel Espinosa, Jessica L Becker, Ji-Dung Luo, Thomas S Carroll, Gary R Fanger

Science· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Delivery of Surface Layer Protein A Protects Mice from Colitis by Re-Setting Host Immune Repertoire.
Ananta Prasad Arukha, Christian Furlan Freguia, Meerambika Mishra, Jyoti K Jha, Subhashinie Kariyawasam, Neil A Fanger, Gary R Fanger

Biomedicines· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.
Jan Scicinski, Bryan Oronsky, Shoucheng Ning, Susan Knox, Donna Peehl, Gary Fanger

Redox Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.
Tony Reid, Bryan Oronsky, Jan Scicinski, Curt L Scribner, Susan J Knox, Gary R Fanger

Lancet Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow the ATP: tumor energy production: a perspective.
Bryan T Oronsky, Neil Oronsky, Gary R Fanger, Christopher W Parker, Scott Z Caroen

Anticancer Agents Med Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent.
Jan Scicinski, George Fisher, Corey Carter, Cheryl Cho-Phan, Pamela Kunz, Gary Fanger

Redox Biol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Going viral: a review of replication-selective oncolytic adenoviruses.
Christopher Larson, Bryan Oronsky, Jan Scicinski, Gary R Fanger, Meaghan Stirn

Oncotarget· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Episensitization: Defying Time's Arrow.
Bryan T Oronsky, Arnold L Oronsky, Michelle Lybeck, Neil C Oronsky, Jan J Scicinski, Gary F Fanger

Front Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Episensitization: therapeutic tumor resensitization by epigenetic agents: a review and reassessment.
Bryan Oronsky, Neil Oronsky, Susan Knox, Gary Fanger, Jan Scicinski

Anticancer Agents Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rewriting the epigenetic code for tumor resensitization: a review.
Bryan Oronsky, Neil Oronsky, Jan Scicinski, Gary Fanger, Michelle Lybeck

Transl Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The implications of hyponitroxia in cancer.
Bryan Oronsky, Gary R Fanger, Neil Oronsky, Susan Knox, Jan Scicinski

Transl Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody.
Yunfeng Zhao, Michael Russ, Marc Retter, Gary Fanger, Charles Morgan

Cancer Immunol Immunother· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VSGP/F-spondin: a new ovarian cancer marker.
Ruth A Pyle-Chenault, John A Stolk, David A Molesh, Dianne Boyle-Harlan, Patricia D McNeill, Gary R Fanger

Tumour Biol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
Marc W Retter, Jeffrey C Johnson, David W Peckham, Jeannette E Bannink, Chaitanya S Bangur, Neil A Fanger, Gary R Fanger

Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.
Rhonda K Yantiss, Bruce A Woda, Gary R Fanger, M Kalos, Giles F Whalen

Am J Surg Pathol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of L985P, a CD20 related family member over-expressed in small cell lung carcinoma.
Chaitanya S Bangur, Jeffrey C Johnson, Ann Switzer, Yi-Hong Wang, Beth Hill, Gary R Fanger

Int J Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Armando Ciampa, Gary Fanger, Ashraf Khan, Kenneth L Rock, Bo Xu

Cancer· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostein expression is highly restricted to normal and malignant prostate tissues.
Michael Kalos, Jon Askaa, Bonnie L Hylander, Elisabeth A Repasky, Feng Cai, Gary R Fanger

Prostate· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma.
Zhong Jiang, Gary R Fanger, Barbara F Banner, Bruce A Woda, Paul Algate

Cancer Detect Prev· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.
Zhong Jiang, Gary R Fanger, Bruce A Woda, Barbara F Banner, Paul Algate

Hum Pathol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel method for increasing the expression level of recombinant proteins.
Aijun Wang, Jonathan Clapper, Jeffery A Guderian, Teresa M Foy, Gary R Fanger

Protein Expr Purif· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum antibodies to lipophilin B detected in late stage breast cancer patients.
Darrick Carter, Davin C Dillon, Lisa D Reynolds, Marc W Retter, Gary Fanger

Clin Cancer Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera.
Craig H Day, Gary R Fanger, Marc W Retter, Bonnie L Hylander, Remedios B Penetrante

Oncogene· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis